LENZ Therapeutics Inc (LENZ) PT Raised at Piper Sandler Amid 'Strong Launch Potential For VIZZ'
Tweet Send to a Friend
Piper Sandler analyst Biren Amin raised the price target on LENZ Therapeutics Inc (NASDAQ: LENZ) to $67.00 (from $51.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
